Dietary Acrylamide-Glycidamide Exposure and Metabolic Toxicity: Emerging Evidence in Type 2 Diabetes.

Jena D, Dey A, Islam A, Gautam MK, Mondal S, Mishra K

Open source

DOI
10.2174/0113816128485741260930182421
Published
2026 Oct 7
Container
Current pharmaceutical design
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2174/0113816128485741260930182421,
  title = {Dietary Acrylamide-Glycidamide Exposure and Metabolic Toxicity: Emerging Evidence in Type 2 Diabetes.},
  author = {Jena D and Dey A and Islam A and Gautam MK and Mondal S and Mishra K},
  year = {2026},
  journal = {Current pharmaceutical design},
  doi = {10.2174/0113816128485741260930182421},
  url = {https://doi.org/10.2174/0113816128485741260930182421}
}

RIS

TY  - JOUR
TI  - Dietary Acrylamide-Glycidamide Exposure and Metabolic Toxicity: Emerging Evidence in Type 2 Diabetes.
AU  - Jena D
AU  - Dey A
AU  - Islam A
AU  - Gautam MK
AU  - Mondal S
AU  - Mishra K
PY  - 2026
JO  - Current pharmaceutical design
DO  - 10.2174/0113816128485741260930182421
UR  - https://doi.org/10.2174/0113816128485741260930182421
ER  - 

APA

D, J., A, D., A, I., MK, G., S, M., & K, M. (2026). Dietary Acrylamide-Glycidamide Exposure and Metabolic Toxicity: Emerging Evidence in Type 2 Diabetes.. Current pharmaceutical design. https://doi.org/10.2174/0113816128485741260930182421

Source records